Tethis: Tethis S.p.A.; Enea TECH; Biomedical Foundation: Enea TECH and Biomedical Foundation invests 15 million in Tethis to develop new diagnostic methods in oncology using liquid biopsy
ROME and MILAN, Jan. 14, 2025 /PRNewswire/ -- Enea TECH and Biomedical Foundation announces a €15 million investment in Tethis S.p.A., a Milan-based company at the forefront of cancer diagnostics....
Read full article »
Tethis is an Italy-based biotechnology company that develops and offers liquid biopsy analysis products for cancer management applications.
Read more